Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Outpatients | 7 | 2024 | 440 | 0.910 |
Why?
|
| Oxygen Inhalation Therapy | 4 | 2026 | 190 | 0.780 |
Why?
|
| Oxygen | 4 | 2026 | 997 | 0.620 |
Why?
|
| Wound Infection | 2 | 2026 | 60 | 0.440 |
Why?
|
| Adenosine Monophosphate | 2 | 2025 | 87 | 0.410 |
Why?
|
| Alanine | 2 | 2025 | 171 | 0.400 |
Why?
|
| Antiviral Agents | 3 | 2025 | 779 | 0.310 |
Why?
|
| Hypoxia | 3 | 2026 | 1211 | 0.310 |
Why?
|
| Wounds and Injuries | 3 | 2026 | 959 | 0.280 |
Why?
|
| Antibodies, Monoclonal | 6 | 2024 | 1512 | 0.260 |
Why?
|
| Hospitalization | 7 | 2025 | 2475 | 0.240 |
Why?
|
| War-Related Injuries | 1 | 2026 | 46 | 0.230 |
Why?
|
| Mullerian Ducts | 1 | 2025 | 16 | 0.220 |
Why?
|
| Prader-Willi Syndrome | 1 | 2025 | 32 | 0.220 |
Why?
|
| Breast Neoplasms | 3 | 2023 | 2418 | 0.220 |
Why?
|
| Uterine Hemorrhage | 1 | 2025 | 41 | 0.220 |
Why?
|
| Hypogonadism | 1 | 2025 | 89 | 0.210 |
Why?
|
| Urogenital Abnormalities | 1 | 2025 | 71 | 0.210 |
Why?
|
| Hormone Replacement Therapy | 1 | 2025 | 107 | 0.210 |
Why?
|
| Health Care Rationing | 1 | 2024 | 54 | 0.200 |
Why?
|
| Levonorgestrel | 1 | 2024 | 34 | 0.200 |
Why?
|
| Intrauterine Devices, Medicated | 1 | 2024 | 27 | 0.200 |
Why?
|
| Abnormalities, Multiple | 1 | 2025 | 195 | 0.190 |
Why?
|
| Antibodies, Viral | 2 | 2024 | 689 | 0.190 |
Why?
|
| Antibodies, Neutralizing | 5 | 2023 | 348 | 0.190 |
Why?
|
| Sentinel Lymph Node | 1 | 2022 | 49 | 0.180 |
Why?
|
| Adult | 17 | 2026 | 41087 | 0.170 |
Why?
|
| Obstetrics | 1 | 2023 | 179 | 0.160 |
Why?
|
| Clinical Trials as Topic | 1 | 2026 | 1064 | 0.160 |
Why?
|
| Gynecology | 1 | 2023 | 185 | 0.160 |
Why?
|
| Gastric Bypass | 1 | 2022 | 115 | 0.160 |
Why?
|
| Burns | 1 | 2025 | 365 | 0.160 |
Why?
|
| Retrospective Studies | 10 | 2026 | 17438 | 0.140 |
Why?
|
| Machine Learning | 1 | 2024 | 594 | 0.140 |
Why?
|
| Critical Illness | 1 | 2025 | 908 | 0.140 |
Why?
|
| Humans | 27 | 2026 | 146342 | 0.140 |
Why?
|
| Body Mass Index | 2 | 2024 | 2458 | 0.130 |
Why?
|
| Obesity, Morbid | 1 | 2022 | 287 | 0.130 |
Why?
|
| Sentinel Lymph Node Biopsy | 3 | 2023 | 118 | 0.130 |
Why?
|
| Kidney | 1 | 2025 | 1498 | 0.130 |
Why?
|
| Lymph Node Excision | 3 | 2023 | 174 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 604 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 927 | 0.120 |
Why?
|
| Mass Screening | 1 | 2025 | 1307 | 0.120 |
Why?
|
| Ukraine | 2 | 2026 | 37 | 0.120 |
Why?
|
| Melanoma | 1 | 2022 | 765 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2024 | 944 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 806 | 0.110 |
Why?
|
| Female | 14 | 2026 | 79499 | 0.100 |
Why?
|
| Middle Aged | 8 | 2026 | 36619 | 0.090 |
Why?
|
| Axilla | 2 | 2023 | 51 | 0.090 |
Why?
|
| Mastectomy | 2 | 2023 | 189 | 0.090 |
Why?
|
| Lymphatic Metastasis | 2 | 2023 | 335 | 0.080 |
Why?
|
| Hospital Mortality | 2 | 2025 | 1051 | 0.080 |
Why?
|
| Aged | 6 | 2026 | 26432 | 0.080 |
Why?
|
| Colorado | 3 | 2025 | 4595 | 0.080 |
Why?
|
| Research Design | 2 | 2026 | 1143 | 0.070 |
Why?
|
| Lymph Nodes | 2 | 2023 | 511 | 0.070 |
Why?
|
| Male | 9 | 2026 | 73396 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2025 | 11821 | 0.070 |
Why?
|
| Young Adult | 4 | 2025 | 14330 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2022 | 992 | 0.060 |
Why?
|
| Puberty, Delayed | 1 | 2025 | 10 | 0.060 |
Why?
|
| Utah | 1 | 2025 | 82 | 0.060 |
Why?
|
| Warfare | 1 | 2026 | 99 | 0.060 |
Why?
|
| Amenorrhea | 1 | 2025 | 35 | 0.060 |
Why?
|
| Burn Units | 1 | 2025 | 40 | 0.060 |
Why?
|
| Adolescent | 4 | 2025 | 22557 | 0.050 |
Why?
|
| Oximetry | 1 | 2026 | 124 | 0.050 |
Why?
|
| Intrauterine Device Expulsion | 1 | 2024 | 9 | 0.050 |
Why?
|
| Congenital Abnormalities | 1 | 2025 | 108 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2026 | 417 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2026 | 368 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2024 | 208 | 0.050 |
Why?
|
| Acute Disease | 1 | 2026 | 1038 | 0.050 |
Why?
|
| Salpingo-oophorectomy | 1 | 2023 | 19 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2024 | 6077 | 0.050 |
Why?
|
| Contraceptive Agents, Female | 1 | 2024 | 80 | 0.050 |
Why?
|
| Multilocus Sequence Typing | 1 | 2022 | 16 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2025 | 615 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2023 | 164 | 0.050 |
Why?
|
| Ritonavir | 1 | 2023 | 76 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2025 | 441 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2025 | 1331 | 0.040 |
Why?
|
| Benchmarking | 1 | 2023 | 193 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2022 | 361 | 0.040 |
Why?
|
| Demography | 1 | 2022 | 274 | 0.040 |
Why?
|
| Pancreatectomy | 1 | 2024 | 289 | 0.040 |
Why?
|
| Health Policy | 1 | 2024 | 399 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2025 | 788 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2024 | 475 | 0.040 |
Why?
|
| Child | 3 | 2025 | 22693 | 0.040 |
Why?
|
| Gastrectomy | 1 | 2022 | 164 | 0.040 |
Why?
|
| Length of Stay | 1 | 2026 | 1358 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2025 | 11913 | 0.040 |
Why?
|
| Patient Safety | 1 | 2023 | 352 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2026 | 1763 | 0.040 |
Why?
|
| Inpatients | 1 | 2023 | 540 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2025 | 925 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 2921 | 0.030 |
Why?
|
| Weight Loss | 1 | 2022 | 858 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2024 | 1210 | 0.030 |
Why?
|
| Vaccination | 1 | 2024 | 1449 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2026 | 1942 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 1998 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2025 | 6460 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 10114 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2023 | 3034 | 0.020 |
Why?
|
| Pregnancy | 1 | 2023 | 7230 | 0.020 |
Why?
|
| Obesity | 1 | 2022 | 3131 | 0.020 |
Why?
|